Type I collagen is the most abundant extracellular matrix protein in bone and other connective tissues and plays key roles in normal and pathological bone formation as well as in connective tissue disorders and fibrosis. Although much is known about the collagen biosynthetic pathway and its regulatory steps, the mechanisms by which it is assembled extracellularly are less clear. We have generated GFPtpz and mCherry-tagged collagen fusion constructs for live imaging of type I collagen assembly by replacing the α2(I)-procollagen N-terminal propeptide with GFPtpz or mCherry. These novel imaging probes were stably transfected into MLO-A5 osteoblast-like cells and fibronectin-null mouse embryonic fibroblasts (FN-null-MEFs) and used for imaging type I collagen assembly dynamics and its dependence on fibronectin. Both fusion proteins coprecipitated with α1(I)-collagen and remained intracellular without ascorbate but were assembled # into α1(I) collagen-containing extracellular fibrils in the presence of ascorbate. Immunogold-EM confirmed their ultrastuctural localization in banded collagen fibrils. Live cell imaging in stablytransfected MLO-A5 cells revealed the highly dynamic nature of collagen assembly and showed that during assembly the fibril networks are continually stretched and contracted due to the underlying cell motion. We also observed that cell-generated forces can physically reshape the collagen fibrils. Using co-cultures of mCherry-and GFPtpz-collagen expressing cells we show that multiple cells contribute collagen to form collagen fiber bundles. ImmunoEM further showed that individual collagen fibrils can receive contributions of collagen from more than one cell. Live cell imaging in FN-null-MEFs expressing GFPtpz-collagen showed that collagen assembly was both dependent upon and dynamically integrated with fibronectin assembly. These GFP-collagen fusion constructs provide a powerful tool for imaging collagen in living cells and have revealed novel and fundamental insights into the dynamic mechanisms for the extracellular assembly of collagen.
INTRODUCTION
Type I collagen is the major structural extracellular matrix (ECM) protein in bone and other connective tissues, such as tendon, ligament and skin. Type I collagen is a heterotrimeric molecule composed of two collagen α1(I) polypeptide chains and one α2(I) chain, encoded by the COL1A1 and COL1A2 genes (reviewed in [1] [2] [3] . Mutations in type I collagen genes are associated with osteogenesis imperfecta (OI), an inherited disorder in which the bones are brittle and susceptible to fracture, and with Ehlers Danlos syndromes of skin laxity and joint hypermobility (reviewed in 4, 5 ). Most cases of OI are caused by mutations in COL1A1 or COL1A2 genes resulting in reduced levels of normal collagen or structural defects of the collagen triple helix. However, mutations in other proteins involved in collagen biosynthesis, such as post translational modifying enzymes, chaperone proteins and processing enzymes, can also result in mild to severe forms of OI (reviewed in 4, 6, 7 ) . Type I collagen is also a key player in fibrosis-related diseases 8 . Therefore, a complete understanding of the mechanisms of collagen biosynthesis and assembly is important for prevention and treatment of these diseases.
While much is known about the collagen biosynthetic pathway and its regulatory steps, less is known about the dynamic mechanisms by which collagen is assembled extracellularly. One approach for examining this is by using live cell imaging techniques. Traditional static imaging of fixed cells and tissues takes a snapshot view at a specific time point, but can miss dynamic aspects of the events being examined. In contrast, live imaging allows visualization of temporal changes in living cells, tissues or whole organisms, and allows quantitation of dynamic cellular, subcellular and tissue behaviors. A few studies have used live imaging approaches to examine assembly of ECM proteins, such as fibronectin, fibrillins, LTBPs and elastin [9] [10] [11] [12] [13] [14] [15] . These studies have shown that assembly of these ECM proteins is highly dynamic and that there are cell-level and tissue-level forces applied to the forming fibrils that stretch and distort them while the matrix is forming. A few investigators have used fluorescently tagged bacterial proteins that bind collagen or have used other collagen binding proteins as probes for imaging collagen in live and fixed cells and tissues [16] [17] [18] . However, to our knowledge, these approaches have not yet been used for long-term time lapse imaging studies to visualize the dynamic mechanisms for extracellular assembly of collagen fibril networks. Additional drawbacks are that these probes are somewhat nonspecific and bind to many types of fibrillar collagens and they are less useful for observing intracellular steps in the assembly process. Second harmonic generation using multiphoton microscopy provides excellent images of fibrillar collagen that has a highly organized structure 19, 20 but this approach may miss earlier events in the assembly process, when collagen fibers are less birefringent. To further enhance our understanding of the dynamic process of collagen assembly, a fluorescently tagged collagen expression construct would be a considerable advance as it would allow visualization of collagen at all stages of the biosynthetic pathway, including intracellular and extracellular steps. A difficult challenge in generating such a construct is the insertion of fusion partners such as green fluorescent protein (GFP), which can add up to 27kDa of peptide sequence to the collagen sequence. In a macromolecule such as collagen, which forms polymers of many collagen molecules packed in an aligned array, careful consideration of the location of a fusion tag is critical.
Here we report the generation of GFP-collagen and mCherry-collagen fusion constructs suitable for imaging collagen assembly dynamics in living cells. Our approach was to replace the N-terminal propeptide of α2(I) procollagen with GFPtopaz or mCherry and overexpress this construct on a background of two wild type α2(I) collagen alleles. We report on the generation and validation of these collagen imaging probes and their use for live imaging of collagen assembly and its dependence on fibronectin.
MATERIALS AND METHODS

GFPtpz-collagen and mCherry-collagen Imaging Probes and pGL3-puro selection vector -
To generate probes for imaging type I collagen, our strategy was to generate cDNA constructs with a GFPtopaz tag (hereafter termed GFPtpz), fused to the Col1a2 sequence.
Three different GFPtpz-α2(I)-collagen constructs were initially engineered (see Fig. 1 ). In construct A, the GFPtpz tag replaced the N-propeptide and N-telopeptide. In construct B, GFPtpz replaced the N-propeptide, but the N-telopeptide was left in frame after GFP. Since the cloning strategy for constructs A and B removes the N-terminal propeptide and its cleavage site, the GFP tag should not be cleaved off during procollagen processing. Construct C was made as a control in which GFP was inserted in front of the N-terminal propeptide. Therefore, the GFP should be cleaved off during processing. The GFPtpz coding sequence was obtained from Packard Instrument Co., Meriden, CT (now licensed to Clontech, Mountainview, CA). Isolation of mouse cDNA for Col1a2 was described previously 21 . A plasmid containing this cDNA (pMSCV-puro-Col1a2) was used as a template for PCR amplification and the amplified Col1a2 constructs were cloned into the pcDNA3 vector (Invitrogen Corp., Carlsbad, CA), which has a CMV promoter.
Two modified versions of construct A were next generated (see Fig 1) . In the first, the mCherry red fluorescent protein (Clontech) was inserted in place of GFPtpz (named construct D). The second was a modified version of construct A in which expression of GFPtpz-collagen was placed under control of a 3.6kb fragment of the Col1a1 promoter (provided by Dr. Barbara Kream, University of Connecticut Health Center) (named construct E). Detailed information on the cloning steps for generating constructs A through E is provided in the supplementary materials (also see supplementary figs S1-S4 and table S1). A puromycin selection vector (pGL3-puro) was made by subcloning the fragment containing promoter-puro cDNA from the pMSCV-puro-Col1a2 vector into the pGL3-basic vector (Promega Corporation, Madison, WI) to replace the luciferase gene. All PCR amplifications were done using high fidelity Deep Vent DNA polymerase (New England Biolabs) and sequences of constructs confirmed by DNA sequencing.
Cell Culture and Cell Lines -
Unless stated otherwise tissue culture reagents were obtained from Gibco (Life Technologies Inc., Grand Island, NY) or Mediatech Inc. (Herndon, VA). Heat inactivated fetal bovine serum (FBS) and calf serum (CS) were obtained from Hyclone Laboratories (GE Healthcare Life Sciences, Logan UT). For transient and stable transfection of GFP-collagen constructs the osteoblast-like cell line, MLO-A5 was used 22 . These cells were maintained in Alpha Modified Minimal Essential Medium (αMEM) supplemented with 5% FBS, 5% CS, 2mM L-glutamine (LG) and 100U/ml penicillin/streptomycin (P/S). To examine the role of fibronectin in collagen assembly, a fibronectin-null mouse embryonic fibroblast cell line was used (FN-null-MEF) and has been described elsewhere 23 (provided by Dr. Deane Mosher, University of Wisconsin, Madison, WI). FN-null-MEFs were maintained in Dulbecco's Modified Eagle Medium (DMEM) with 10% FBS, 2mM LG, 100U/ml P/S and nonessential amino acids (1:100 dilution of 100x solution). For experiments to determine the role of fibronectin in collagen assembly, the cells were cultured in media with 10% fibronectin-stripped FBS, prepared by adsorption over gelatin sepharose as described elsewhere 24 with or without addition of plasma fibronectin (Life Technologies Inc.) or fluorescently labeled fibronectin (see below for details) as described in figure legends.
Transfection of GFPtpz and mCherry Collagen Constructs -
GFPtpz and mCherry-collagen expression plasmids were purified using endotoxin-free plasmid purification kits (Qiagen Inc., Valencia, CA). Transfection was performed using the Lipofectamine 2000 reagent and Optimem culture medium containing serum but no antibiotics according to manufacturer's instructions (Life Technologies Inc.). For transient transfection experiments, cells were cultured in growth media (see above) with 50µg/ml ascorbic acid for 3-6 days following transfection before evaluation of GFP-collagen fluorescence in the ECM. Media was changed at confluence then every 3 days. To ensure continued collagen assembly, fresh ascorbic acid was added daily to the media. Alternatively, the more stable L-ascorbic acid phosphate magnesium salt n-hydrate was used (Wako Chemicals USA, Inc. Richmond VA). co-transfecting construct A at a 10:1 ratio with the pGL3-puro (puromycin resistance) vector. Construct A was used because in transient transfection experiments it showed more robust expression/brighter GFP-collagen fibers compared to construct B. Also, we were concerned that the GFPtpz in construct B might be cleaved off by endogenous telopeptidases, based on a report by Bateman et al 25 showing that fibroblasts produce proteases that can remove N and C-terminal type I collagen telopeptides. Transfection was done using Lipofectamine 2000, as above. Puromycin-resistant single cell clones were screened based on their ability to generate a fluorescent GFP-collagen fibrillar network after 3-6 days with ascorbic acid. For screening, the cells were cultured in media with 10% FBS, which provides sufficient plasma fibronectin to facilitate collagen assembly. Clone# FNnull-MEF-colGFP-I-1 was the best GFPtpz-collagen producing clone and is hereafter referred to as FNKO-colGFP.
Next, an MLO-A5 cell line stably expressing mCherry-collagen construct D was generated. Transfection was performed as above. Since construct D has a neomycin resistance gene, G418 (neomycin)-resistant cells were cloned by limiting dilution. To generate an MLO-A5 cell line stably expressing GFPtpz-collagen, construct E was co-transfected at a 10:1 ratio with the vector pcDNA3 (Invitrogen), which has a neomycin resistance gene. Single cell G418-resistant clones were screened based on their ability to generate a fluorescent GFPtpzcollagen or mCherry-collagen fibrillar network within 3-6 days with ascorbic acid (50-100µg/ml). Clone# MLO-colCherry-F22S was the best mCherry-collagen producing clone and clone# MLO-colGFP-B2 was the best GFPtpz-collagen producing clone. These two clones are hereafter referred to as MLO-colCherry and MLO-colGFP.
Static and Live Cell Imaging of Collagen and Fibronectin Assembly -
For static imaging of collagen assembly, cells were plated into collagen coated multiwell plates or plastic lab-tek chamber slides (Nalge Nunc/ Thermo Fisher Scientific, Waltham, MA) at 2 × 10 4 cells/cm 2 plate area. At confluence, fresh media was added containing 50-100µg/ml ascorbic acid and the cells were cultured for a further 3-6 days to allow collagen deposition. Fresh ascorbic acid was added daily or the stable L-ascorbic acid phosphate magnesium salt n-hydrate was used. The cultures were fixed in 4% paraformaldehyde in PBS. Some samples were counterstained with 4',6-Diamidino-2-Phenylindole, Dihydrochloride (DAPI) or the membrane dye Vybrant DiD (Molecular Probes/Thermo Fisher Scientific) according to manufacturer protocols, with the modification that the DiD stain was diluted in Diluent C (cat# CGLDI: Sigma-Adrich Corp. St Louis, MO) to improve stain penetration. The samples were imaged on a Nikon TE300 widefield epifluoresence microscope with a 10× 0.3 NA or 20× 0.45 NA objective and a Photometrics Coolsnap EZ cooled CCD camera interfaced with PM Capture Pro software (Photometrics, Tucson, AZ). Alternatively, they were imaged on a Leica TCS Sp5 II scanning confocal microscope with a 20× 0.7 NA or 100x oil 1.44NA objective interfaced with LAS-AF software (Leica Microsystems, Wetzlar, Germany). Filter sets and confocal settings were optimized for each fluorophore. To examine whether multiple cells cooperate to assemble collagen, three types of co-culture experiments were set up, including: A) co-culturing MLO-colGFP and MLO-colCherry cell lines at a 1:1 ratio; B) "parachute" experiments in which MLO-colCherry cells were plated at low density onto a layer of MLO-colGFP cells; and C) "interface" experiments in which the two cell lines were plated separately at high density in 25µl droplets, which were allowed to grow towards each other, creating an interface (see supplementary methods for details).
For live imaging, cells were plated on collagen-coated glass coverslip-bottomed lab-tek chamber slides (Nalge Nunc/Thermo Fisher Scientific). Media was changed for fresh media with 50-100µg/ml ascorbic acid just prior to imaging. Ascorbic acid was added daily or the stable L-ascorbic acid phosphate magnesium salt n-hydrate was used. In some experiments with FNKO-colGFP cells, the GFPtpz-collagen was imaged simultaneously with fibronectin using an alexa555 labeled human plasma fibronectin probe. This probe was prepared as described previously 15, 26 using an Alexafluor-555 protein labeling kit (Molecular Probes/ Thermo Fisher Scientific). The probe was added to the culture medium containing 10% fibronectin stripped FBS at 2.5µg/ml together with 7.5µg/ml unlabeled plasma fibronectin.
Live cell imaging was performed on an automated Nikon TE 2000E microscope with precision motorized x, y and z stage using a 20× 0.75 NA objective under epifluorescence illumination with filter sets optimized for GFPtpz, mCherry or alexa555. The "Metamorph" software (Molecular Devices, LLC, Sunnyvale, CA) controlled the microscope and multidimensional imaging parameters. Temperature was held constant at 37°C using a microscope incubator cabinet ("The Cube", Life Imaging Systems, Reinach, Switzerland) and a humidified 5% CO 2 atmosphere was maintained using a gas mixer ("The Brick", Life Imaging Systems) in conjunction with a stage top incubation chamber. Images were acquired for each time point under epifluorescent illumination using a Photometrics Coolsnap HQ cooled CCD camera with 12-bit grey scale resolution. Fields of 450 × 335µm were imaged at a spatial resolution of 696 × 520 pixels (2×2 binned mode) every 15-30 minutes for up to 58h from 5-7 optical planes. Image stacks were processed in Metamorph using the "best focus" algorithm or by manually selecting the best focus plane and were exported as image stack (.stk) files. Contrast adjustments, red-green merging, conversion to 8-bit stacks and compilation into movies was done using Image J software (Rasband, W.S., ImageJ, NIH, Bethesda, Maryland, USA, http://imagej.nih.gov/ij/). The "stackreg" plugin in Image J 27 was used to align the image stacks and correct for rigid body motion. Aligned stacks were assembled into movies using Image J.
Quantitation of Collagen and Fibronectin Co-localization and Assembly Dynamics -
For co-localization analysis, the Pearson's and Mander's Coefficients were determined using the JACoP plugin for ImageJ 28 . Image stacks were background subtracted in ImageJ and thresholding values for determining Mander's coefficient were calculated using the Costes thresholding function of the JACoP plugin on a representative movie stack. The same threshold was applied to all stacks in the analysis. Pearson's coefficient was validated using the Costes randomization feature in JACoP with 200 iterations. To quantify fibronectin and collagen assembly kinetics, background subtracted movie stacks were thresholded in image J and fibril area was quantified from thresholded stacks using the Multi Measure Plugin in Image J.
Antibodies -
Antibodies included a rabbit polyclonal and a rabbit monoclonal anti-GFP (Ab 290: Abcam, Cambridge, MA. and G10362: Invitrogen/Life Technologies Inc.), a mouse monoclonal anti-GFP (JL-8: Clontech) and a rabbit polyclonal anti-COL1A2 (Ab96723: Abcam). Rabbit polyclonal or mouse monoclonal anti-DsRed antibodies (632496 & 632392: Clontech) were used for detection of mCherry, which is a DsRed derivative. For type I collagen, the LF67 rabbit antiserum was used (provided by Dr. Larry Fisher, NIDCR, Bethesda, MD) 29 , which recognizes the collagen α1(I) chain. Secondary antibodies for immunogold-EM and immunofluorescent staining included a 6nm gold-conjugated anti-rabbit, a 12nm goldconjugated anti-mouse and a Cy3-anti-rabbit (711-195-152; 715-205-150 and 711-165-152: Jackson Immunoresearch Laboratories Inc., West Grove, PA). Detection antibodies for Western blotting included a peroxidase conjugated anti-mouse (#31430: Thermo Fisher Scientific) and a peroxidase conjugated anti-Rabbit (111-035-144: Jackson ImmunoResearch). For direct detection of β-actin on Western blots a peroxidase conjugated anti-β-actin antibody was used (A3854, Sigma).
Immunofluorescent Staining -
Cells were grown in collagen coated coverslip-bottomed chamber slides and immunostaining was performed as described previously 30 following fixation in 4% paraformaldehyde in PBS. Type I collagen was detected using the LF67 antiserum in conjunction with a Cy3-anti-rabbit antibody (see above). Non-immune rabbit serum was used as a negative control. Stained slides were photographed on the Nikon TE2000E microscope as described above with a 20× 0.75 NA objective.
Immunogold Staining and Transmission Electron Microscopy -
For immunogold staining, cells were grown on thermanox coverslips (Nalge Nunc/ Thermo Fisher Scientific) in 24 well plates in 1ml media and immunogold labeling was performed on viable cultures without prior fixation as described previously 30 with modifications as detailed in the supplementary methods. After immunogold staining and post-fixation, the samples were dehydrated and embedded in epoxy resin (Embed-812, Electron Microscopy Sciences, Hatfield, PA). Ultrathin sections were cut on an EM UC7 ultramicrotome (Leica Microsystems Inc., Buffalo Grove, IL), stained with uranyl acetate and lead citrate and observed with a CM12 electron microscope (FEI, Hillsboro, OR) at 80 kV accelerating voltage.
Western Blotting -
Western blotting was performed as described previously 30, 31 with modifications. Briefly, cell layers were rinsed twice in PBS and lysed in ice-cold RIPA buffer (25mM Tris-HCl pH 7.6, 150mM NaCl, 1% NP-40, 1% sodium deoxycholate, 0.1% SDS) containing protease inhibitor cocktail (Sigma cat# P8340) and 3mM EDTA, with all steps performed on ice. 20 or 40µg of total protein per sample was separated on 8% SDS-PAGE gels and electroblotted overnight at 18V constant voltage onto PVDF membrane in transfer buffer (25mM Tris, 192mM glycine, 20% methanol, 0.01% SDS, pH 8.3). Membranes were blocked in TBS + 5% BSA/1% milk and incubated overnight at 4 o C with primary antibodies followed by washing and incubation with peroxidase conjugated secondary antibodies. Immunoreactive bands were visualized using the SuperSignal West Dura or Femto Chemiluminescence kits (ThermoFisher Scientific) and imaged on a Fujifilm LAS 4000 gel documentation system using the Multi-gauge software (Fujifilm, Tokyo, Japan). Blots were stripped using Restore stripping buffer (Thermo Fisher Scientific) and re-probed with other primary antibodies of interest then lastly probed with HRP-anti-β-actin to confirm equal protein loading. Densitometry was performed using the Multi-gauge software.
Co-Immunoprecipitation -
24h conditioned media were collected from day 4 post confluent cultures of GFPtpz-and mCherry-collagen stable cell lines (15ml per 150mm dish). The media was supplemented with 50µg/ml ascorbic acid and FBS was reduced to 0.5%. Samples were kept on ice throughout the procedures. Protease inhibitors were added to the 15ml media samples as follows: phenylmethylsulfonyl fluoride (150µl of 100mM stock in EtOH), pepstatin-A (60µl of 1mg/ml stock in 95% EtOH) and N-Ethylmaleimide (1.5ml of 67mM stock in PBS/0.3M EDTA). Next, collagen was extracted from the cell layer by sequential extractions with a salt buffer to release recently secreted tropocollagen, an acid extraction buffer to release noncrosslinked collagen, followed by pepsin extraction to release pepsin-soluble collagen (see supplementary methods for details of collagen extraction procedure).
The Pierce Classic IP kit (Pierce/Thermo Fisher Scientific) was used for immunoprecipitation according to manufacturer's instructions, with modifications as detailed in the supplementary methods. 600µl media samples were used for immunoprecipitation (with 50mM Tris pH 7.4 added to stabilize pH). For salt, acid or pepsin extracts a 30kDa MWCO microcon filter (EMD Millipore, Billerica, MA) was used to exchange the buffer to IP lysis/wash buffer prior to immunoprecipitation. Samples were immuno-precipitated with rabbit polyclonal antibodies to GFP or mCherry to precipitate the fluorescently tagged α2(I) collagen or with normal rabbit IgG as a control to show specificity (see supplementary methods for details). Immunoprecipitates were electrophoresed on 5% precast Criterion SDS PAGE gels (Biorad Laboratories, Hercules, CA). Electroblotting and Western blotting were performed as described above using the LF67 antibody against collagen α1(I) with the exception that the Clean-Blot IP detection kit was used (Pierce/Thermo Fisher Scientific). This reagent only detects native IgG and reduces background bands from denatured IgG present in the immunoprecipitates. The clean blot signal was detected using the chemiluminescence reagent in the Clean-Blot kit and imaged on the Fujifilm LAS 4000 system as above.
RESULTS
Transient Transfection Shows Incorporation of GFPtpz-Collagen into Extracellular Fibril Networks -
GFPtpz-collagen constructs A, B and C were transiently transfected into MLO-A5 late osteoblast-like cells (Fig. 2 , upper panels). 5 days after transfection, constructs A and B were localized in extracellular fibril networks, as expected. This is because the GFPtpz tag replaced the N-propeptide and N-telopeptide (construct A) or the N-propeptide (construct B) of α2(I) procollagen, removing the N-terminal propeptide cleavage site. Therefore, the GFP moiety should not be cleaved off during collagen processing. With construct C, a few cells showed intracellular GFP fluorescence (arrowheads), but there was no GFP signal in mature collagen fibrils. This is as expected, since the GFPtpz tag in construct C was inserted before the N-terminal propeptide. Therefore, GFP-tagged procollagen should be visible intracellularly prior to N-terminal propeptide cleavage but the GFP tag would be removed during N-terminal procollagen processing, so there should be no fluorescent signal in the collagen fibril network.
Several studies have shown a key role for fibronectin in assembly of type I collagen [32] [33] [34] . Therefore, the GFPtpz-collagen constructs were also transiently transfected into FN-null-MEFs (Fig, 2 , lower panels) with the aim of making a stable GFP-collagen expressing cell line to investigate the regulation of collagen assembly by fibronectin. For these experiments the FN-null-MEFs were cultured in media with 10% FBS, which provides sufficient plasma fibronectin to enable collagen assembly. In FN-null-MEFs, constructs A and B formed GFPpositive extracellular fibrils and construct C did not. These data suggest that in both cell lines, constructs A and B were secreted and incorporated into extracellular fibrils as predicted.
Generation of Stable Cell Lines Expressing GFPtpz-collagen and mCherry-collagen and Validation of the Expression Constructs -
Stable cell lines were next generated expressing GFPtpz and mCherry-collagen. The first was a stable line of FN-null-MEFs transfected with construct A, referred to as FNKO-colGFP. Note that for screening and validation experiments, the cells were cultured in 10% FBS, which provides sufficient plasma fibronectin to enable collagen assembly. Fig. 3A shows robust expression of GFPtpz-collagen in the FNKO-colGFP cell line. Without ascorbate (without AA) the GFP signal remained intracellular, with a perinuclear distribution suggesting localization in the endoplasmic reticulum (ER). In contrast, with ascorbate (with AA), the GFPtpz-collagen was secreted and assembled into a well organized fibril network. Confocal imaging of GFP together with a cell membrane dye confirmed the intracellular localization of the GFPtpz-collagen without ascorbate and extracellular fibrillar localization with ascorbate (see supplementary fig. S5A ). Transmission electron microscopy (TEM) showed no gross abnormalities of the collagen fibrils in FNKO-colGFP cells compared to untransfected controls (Fig. 3B ). The fibril appearance and thickness was normal and they retained their classic banded appearance. Immunostaining with LF67 antibody [against α1(I) collagen], showed colocalization with GFPtpz in fibrils in the presence of ascorbate ( Fig. 3C , middle panels), confirming that the GFPtpz tagged α2(I) collagen was incorporated into fibrils containing α1(I) collagen. Without ascorbate, there was no fibrillar collagen and LF67 immunostaining did not co-localize precisely with the intracellular GFPtpz-collagen signal using standard staining conditions that did not include a permeabilization step (fig 3C, upper panels). However, with triton permeabilization to allow antibody penetration into the cell, the LF67 immunostaining co-localized intracellularly with GFP (see supplementary fig. S5B ). Immunogold-EM was next performed. Figure 3D shows that there was negligible background gold labeling of collagen fibrils with a control IgG. In contrast, with anti-GFP antibody, extensive gold labeling of banded collagen fibrils was seen with very little label "off fibril", further confirming that the GFPtpz-collagen was incorporated into authentic collagen fibrils.
To further validate the GFPtpz-collagen construct, co-immunoprecipitation (Co-IP) experiments were done. Conditioned media from FNKO-colGFP cells or untransfected FNnull-MEFs was immunoprecipitated with GFP antibodies to pull down the GFPtpz-tagged collagen and immunoblotted with LF67 antibody against collagen α1(I). Fig. 3E shows that a band was seen at ~120-125kDa, corresponding to α1(I) collagen (red arrow). This band was seen in FNKO-colGFP cells but not untransfected controls or samples precipitated with control IgG. These data showing pull-down of α1(I) collagen with GFPtpz-collagen, suggest that the GFPtpz-tagged α2(I) chains associate with α1(I) and likely participate in heterotrimer formation. Western blotting on cell lysates using α2(I) collagen antibodies ( Fig.  3F ; COL1A2) showed endogenous α2(I) procollagen running at ~150kDa and the GFPtpztagged α2(I) band running slightly higher. This band was seen in FNKO-colGFP but not untransfected control cells (Fig. 3F ; GFP and merged images). Densitometric quantitation showed that the GFP tagged collagen represented a minor fraction (12 ± 0.3 %) of the total α2(I) collagen.
Two stable MLO-A5 cell lines were next generated expressing mCherry-collagen construct D and GFPtpz-collagen construct E. The MLO-A5 cell line represents a late osteoblast phenotype that mineralizes and produces copious amounts of collagen 22 , making it ideal for examining collagen assembly dynamics. Robust expression of mCherry-or GFPtpz-collagen was seen in stably transfected MLO-colCherry and MLO-colGFP cell lines (Fig. 4A) . The GFPtpz or mCherry-collagen remained intracellular without ascorbate ( fig 4A and  supplementary figure S6A ) but with ascorbate, extensive mCherry or GFPtpz-positive ECM fibrils were formed ( fig 4A) . Confocal optical sectioning of MLO-colGFP cultures stained with the membrane dye DiD showed that the GFP-tagged collagen was deposited mostly below the basal surface of the cells ( fig 4B & supplementary figure S6A ). The GFPtpzcollagen fusion protein in construct E is identical to that already validated for the FNKO-colGFP cells. To further validate the mCherry-collagen fusion protein, immunogold EM was performed in MLO-colCherry cells ( Fig 4C) . Using antibody to DsRed (which recognizes mCherry), specific gold labeling of banded collagen fibrils was seen with very little label "off fibril", suggesting the mCherry-collagen was incorporated into authentic collagen fibrils. Controls with normal IgG in place of primary antibody showed negligible background labeling.
Co-IP studies were next performed. Samples were immunoprecipitated with DsRed antibodies to pull down the mCherry-tagged collagen and immunoblotted with LF67 antibody. In immunoprecipitates from MLO-colCherry conditioned media a major LF67reacting band was seen, representing fully processed α1(I) collagen, with minor bands corresponding to partially processed forms in which either the C-terminal or N-terminal propeptide was retained [Proα1(I) N-and Proα1(I) C-respectively] (Fig. 4D) . These bands were not seen in untransfected parental cells or samples precipitated with control IgG. Co-IP was also performed on extracts of the cell layer including a salt extract, which should release recently secreted tropocollagen, an acid extract, which should release crosslinked collagen, and a pepsin extract, which should release remaining pepsin soluble collagen. No bands were seen in the acid or pepsin extracts (not shown), likely because acid disrupts the GFP and mCherry structure and may disrupt epitopes recognized by the antibody. In the salt extract, a single band representing fully processed α1(I) collagen was seen, suggesting the partially processed α1(I) chains were not incorporated into the ECM. These data confirm that the mCherry-α2(I) collagen associates with α1(I) chains. Western blotting on MLO-colGFP and MLO-colCherry cell lysates using α2(I) collagen antibody (supplementary figure S6B, COL1A2) showed the endogenous α2(I) procollagen running at ~150kDa with the GFPtpz-and mCherry-tagged bands running slightly higher. Densitometric quantitation showed that the GFPtpz-and mCherry-tagged collagen represented a minor fraction of the total α2(I) collagen (7.6 ± 0.9 % and 2.2 ± 0.2 %, respectively).
Live Imaging of Collagen Assembly in Stably Transfected MLO-A5 Cell Lines -
Having validated that the GFPtpz and mCherry collagen fusion constructs behaved similarly to the endogenous protein, live cell imaging studies were performed to gain new insight into the dynamic mechanisms of collagen assembly. Fig. 5 shows still frames from a representative time-lapse movie of MLO-colGFP cells imaged without ascorbate (Fig. 5A , without AA) and with ascorbate ( Fig. 5B , with AA). Supplementary movies 1 and 2 should be viewed to appreciate the dynamic nature of the collagen assembly process. Without ascorbate (Fig. 5A, & movie 1) , the GFPtpz-collagen retained a diffuse perinuclear ER-like distribution. No extracellular collagen fibril assembly was observed over the entire time course. In contrast, with ascorbate ( Fig. 5B & movie 2 ) an extensive collagen matrix was assembled by 48h. The active nature of the collagen assembly process is best appreciated by viewing movie 2, showing collagen assembly in MLO-colGFP cells with cell motion imaged by differential interference contrast (DIC). From these movies a key novel finding was that collagen assembly is highly dynamic, with the cells constantly in motion throughout the assembly process. This motion exerts forces on the forming fibrils that stretch and contract them repeatedly during their assembly. By 2-8h after ascorbate addition, the GFPtpzcollagen moved from a diffuse perinuclear localization into intracellular vesicle-like packets that moved extensively within the cells (Fig, 5B -8h & movie 2, white arrowheads). By 11-14h, a few wispy collagen fibers were deposited in the ECM (Fig. 5B-14h , open arrowheads and movie 2), which were often observed around the cell periphery and between adjacent cells. A more extensive collagen matrix was seen by 24 through 48h.
Another key observation was that the cells were able to physically reshape the collagen matrix by pushing collagen fibrils outwards to generate "holes" in the fibril network (movie 2 & Fig. 5B -compare white arrows at 36h & 48h). Figs. 6A & 6B show higher magnification images to illustrate cell-mediated physical reshaping of the collagen matrix. In Fig. 6A , a small hole appears at 33h 40min (arrow), which enlarges further between 35h 20min to 48h 40 min. A second hole appears adjacent to the first hole at 48h 40 min (arrowhead). In addition, a large hole at the top of the image (open arrow) enlarges throughout the time series. Fig. 6B shows two holes (arrow and open arrow) at 44h 20min that enlarge over the time series. From the merged DIC-GFPtpz-collagen panel of movie 2, it appears that the outline of these holes corresponds to the outline of the nucleus in the underlying cell. Interestingly, when the cells underwent division, the GFP-collagen was split equally between daughter cells. Fig. 6C shows still images of a cell, X, from movie 1 (without AA), which rounds up by 3h and divides by 5h 20min, with the collagen equally divided between daughter cells X 1 and X 2 . Fig. 6D shows still images of two cells, Y and Z, from movie 2 (with AA), that round up. By 19h 40 min, cell Z divides into daughter cells Z 1 and Z 2 and by 20h cell Y divides into daughter cells Y 1 and Y 2 . In both cases the collagen is equally divided between daughter cells.
Multiple Cells Cooperate in the Assembly of Collagen Fibers -
To examine whether individual osteoblasts assemble their own collagen fibers or multiple cells cooperate to assemble collagen, we took advantage of the MLO-A5 cell lines expressing red or green fluorescently tagged collagen. Three types of co-culture experiments were set up (see Fig. 7 ). These included: (A) co-culturing the two cell lines at a 1:1 ratio; (B) "parachute" experiments in which MLO-colCherry cells were plated at low density onto a confluent layer of MLO-colGFP cells; and (C) "interface" experiments in which MLO-colGFP or MLO-colCherry cells were plated separately at high density in 25µl droplets, to form colonies, which were then allowed to grow towards each other to create an interface of red and green collagen expressing cells. If multiple cells co-operate to assemble collagen, we would expect to see fibers containing both red and green collagen. However, if individual cells assemble their own collagen fibers without contributions from other cells, we would expect separate patches of green or red fibers, but not fibers containing both red and green collagen. Co-culture experiments with a 1:1 ratio of MLO-colGFP and MLO-colCherry cells resulted in formation of collagen fibers with green and red collagen co-localized in the same fiber bundles (Fig. 7A) . Similarly, using the "parachute" design ( Fig. 7B ), the fibers that formed around parachuted cells contained red collagen from the parachuted cells together with green collagen from the confluent cell layer. These findings were further confirmed by the "interface" design ( Fig. 7C ) in which the collagen fibers formed at the interface between MLO-colGFP and MLO-colCherry cells (C2) contained red and green collagen in the same fibers. In contrast, away from the interface the fibers contained only green collagen on the MLO-colGFP cell side (C1) or only red collagen on the MLO-colCherry side (C3).
To further examine at the ultrastructural level whether collagen from two different cells can be deposited in the same fibril, double immunogold labeling TEM was performed in 1:1 cocultures of MLO-colGFP and MLO-colCherry cells. The GFPtpz-collagen was detected with 12nm gold particles and mCherry-collagen was detected with 6nm gold. Fig. 7D shows that in co-cultures of MLO-colGFP and MLO-colCherry cells, several banded collagen fibrils were observed that labeled with both 6nm and 12nm gold particles, suggesting the collagen fibrils contained contributions from more than one cell. Negligible background labeling of collagen was seen in IgG controls. This suggests that cells cooperate in assembly of collagen fibers and multiple cells provide contributions to form individual fibrils and fiber bundles.
To examine dynamically the co-deposition of red and green collagen, timelapse imaging was performed in 1:1 co-cultures of MLO-colGFP and MLO-colCherry cells. As shown in supplementary movie 3 the mCherry-collagen and GFPtpz-collagen were localized in separate cell populations at 0h. Faint red and green collagen fibers formed by 16h after ascorbate addition, with a well formed network by 48h. In areas where both red and green collagen producing cells were present, the GFPtpz and mCherry collagen was localized in the same fibrillar structures, which showed similar stretching and contraction motions due to underlying cell motion. Supplementary Fig. S7 shows representative still frame images from movie 3.
Integration of Collagen Assembly Dynamics with Fibronectin Assembly -
Fibronectin is one of the earliest proteins to be assembled into the ECM and regulates assembly of collagen [32] [33] [34] . To understand how collagen and fibronectin assembly are dynamically integrated, FNKO-colGFP cells were used. These experiments were done in medium with 10% FN-stripped FBS so the availability of fibronectin could be experimentally controlled. This model therefore allows us to initiate de novo fibronectin assembly from a zero baseline. Fig. 8 shows still frames from a time lapse movie of FNKO-colGFP cells imaged over 46h without fibronectin (Fig. 8A, without FN) and with 10μg/ml plasma fibronectin (Fig. 8A, with FN) . After ascorbate addition, regardless of whether fibronectin was present, the GFPtpz-collagen migrated from a perinuclear localization into vesicle-like structures as seen in MLO-colGFP cells (Fig, 8A open arrowheads) . Without fibronectin the cells failed to form any GFP-collagen fibrils by 18h and only a few sparse fibrils were formed by 46h (arrows). In contrast, with fibronectin, a few GFP-collagen fibrils were seen by 18h (arrows) with more fibrils by 46h (arrows). Supplementary movie 4 should be viewed to appreciate the collagen assembly dynamics with and without fibronectin. Quantitation confirmed a dramatic decrease in GFP-collagen fibril area in the absence of fibronectin (Fig. 8B) .
To determine if fibronectin and collagen are co-assembled and define their assembly kinetics, FNKO-colGFP cells were cultured in FN-stripped serum then provided with 2.5µg/ml alexa555-labeled fibronectin (alexa555-FN) and 7.5µg/ml unlabeled fibronectin (FN) at the start of imaging. This served to both initiate fibronectin assembly and enable covisualization of fibronectin and collagen. In these experiments ascorbate was added prior to and during imaging to maximize collagen assembly. Fig. 9A shows still images from a timelapse movie of collagen and fibronectin assembly. Supplementary movie 5 should be viewed to appreciate the dynamic events. Fibronectin fibrils were assembled within 3-4h and were clearly visible by 5h. A few collagen fibrils were assembled by 5h but collagen assembly lagged behind fibronectin. By 24 and 48h a complex network of fibronectin and collagen fibrils was formed. At all time points, collagen was co-deposited with fibronectin and the forming collagen and fibronectin fibril networks showed identical motions and displacements, suggesting their assembly is integrated. A small portion of the GFPtpzcollagen did not co-localize with fibronectin, which mainly represented intracellular GFPtpz-collagen that had not been secreted (arrowheads). Supplementary Fig. S8 provides additional controls to show that our observations of collagen and fibronectin co-deposition were not due to signal bleed through between imaging channels.
To quantify the degree of collagen and fibronectin co-localization, the Pearson's and Mander's coefficients were plotted as a function of time (Fig. 9B ). Pearson's coefficient is a measure of the degree of correlation of red-green image pairs and Mander's M1 coefficient measures the fraction of the GFPtpz-collagen that overlaps with fibronectin in image pairs. Both the Pearson's and Mander's coefficients increased over the 46h time course, confirming that as matrix assembly progresses more collagen is co-localized with fibronectin. Quantitation of fibronectin and collagen assembly kinetics (Fig. 9C ) showed a similar temporal profile, with fibronectin being initially deposited more rapidly than collagen. Fig. 10 shows static images of longer term cultures of FNKO-colGFP cells imaged after 3 or 6 days in the presence of 2.5µg/ml alexa 555-FN and 7.5µg/ml unlabeled FN. At day 3 the alexa555-FN and GFP-collagen were co-localized in the same fibrillar structures, with only a few collagen fibers that were not associated with fibronectin (arrowheads). By day 6, a much more extensive collagen fibril network had formed but there was less fibronectin and less co-localization of collagen with fibronectin, suggesting that the fibronectin may form a temporary scaffold for collagen deposition, but as the matrix matures, they are localized in separate networks. Measurement of the Mander's M1 coefficient for the fraction of collagen co-localized with fibronectin confirmed that much more of the collagen was co-localized with fibronectin at day 3 compared to day 6 (see fig. 10B )
DISCUSSION
Here we describe the generation of GFPtpz and mCherry-collagen constructs, their validation and their use for live imaging of collagen assembly dynamics and examining the role of fibronectin in collagen assembly. Their success was likely due to the strategy of placing the GFPtpz or mCherry tag on the proα2(I) collagen chain, which should result in collagen trimers containing a single GFP moiety, since there is only one α2(I) chain per trimer. In theory, this would be less disruptive than targeting the proα1(I) chain, which could result in trimers with two GFP moieties or possibly three, since α1(I) chains, can form homotrimers. Targeting the GFP-tag to the N-terminus also avoids the C-terminus, which is critical for nucleation of collagen chains to form trimers. Rather than adding extra sequence, the N-terminal propeptide was replaced with GFP. This was based on a paper by Eyre et al 35 reporting a mutation in Ehlers Danlos Syndrome type VII resulting in loss of the Nproteinase cleavage site in the proα2(I) chain. Although these patients retain the Npropeptide of their α2(I) collagen, the mutant α2(I) chains participate in trimer formation and patients have no clinical signs of bone disease. Since the size of the retained Npropeptide in these patients is similar to GFP, we reasoned that the GFP-tag could potentially be accommodated in the α2(I) N-terminus without preventing incorporation into collagen trimers and assembly into fibrils. Additionally, it is important to emphasize that our GFPtpz and mCherry-collagen constructs were expressed on a background of two wild-type Col1a2 alleles. This would likely reduce the severity of potential collagen abnormalities associated with the GFP insertion compared to Ehlers Danlos patients who have one normal and one mutated allele, resulting in 50% abnormal collagen chains. In support of this concept, Hulmes et al 36 , studied the in vitro assembly of partially processed type I collagen in which the N-terminal propeptide was not cleaved (pN-collagen). This pN-collagen is similar to collagen in some types of Ehlers Danlos syndrome where the N-terminal propeptide is retained. They showed that "ragged" fibril abnormalities resembling Ehlers Danlos collagen fibrils only occurred when the pN-collagen-to-collagen ratio was 44% or higher. If the pN-collagen fraction was less than 25%, the fibrils were indistinguishable from those formed with 100% collagen. Interestingly, we found that our GFPtpz and mCherry-tagged constructs represented a minor fraction (12% or less) of the total α2(I) collagen suggesting that, while they are useful as probes, they may be present at levels that are sufficiently low to have minimal effects on collagen assembly.
In transient transfection, the GFP-collagen constructs worked as expected. Constructs A and B localized to extracellular fibrils as predicted, since the GFP tag replaced the N-terminal propeptide and was not cleaved off during processing. The control construct C was not found in mature collagen fibers, as expected, since the GFP tag preceded the N-terminal propeptide and should be cleaved off during procollagen processing. Stable MLO-A5 and FN-null-MEF cell lines were therefore made expressing GFPtpz-and mCherry-collagen and validation experiments confirmed that the GFPtpz and mCherry-collagen behaved similarly to wild type α2(I) chains in terms of their intra and extracellular localizations with and without ascorbate and their ultrastructural localization in banded collagen fibrils, which appeared normal. Immunostaining and co-IP studies confirmed that the GFPtpz or mCherry-α2(I) collagen chains associate with α1(I) collagen. Together, these data show that incorporation of GFPtpz or mCherry into the α2(I) collagen N-terminus can be accommodated without preventing incorporation into collagen fibrils.
Although the GFPtpz and mCherry-collagen constructs behaved similarly to wild-type α2(I) chains, it is important to emphasize that we cannot exclude other more subtle abnormalities in the collagen fibrils and/or collagen trafficking, post-translational modification, secretion, processing or crosslinking due to the GFPtpz and mCherry insertions in the fusion proteins. Indeed, it seems unlikely that the collagen fibrils would be completely normal with the large GFP protein tag and this should always be considered when interpreting data. Nevertheless, with these caveats in mind, the data suggest that these constructs are a useful and relevant tool for imaging collagen assembly in living cells that can provide novel insight into the dynamic process of collagen assembly.
Two main models have been proposed to explain collagen fibrillogenesis (reviewed in 3 ). In the Kadler model 37 procollagen trimers are carried to the plasma membrane in golgi-toplasma membrane carriers (GPCs). As the GPCs travel to the plasma membrane, they fuse to form larger vacuoles. Kadler proposes that procollagen is cleaved to tropocollagen in the fused GPCs and the collagen molecules align to form a fibril. Therefore, initial fibrillogenesis begins intracellularly inside fused GPCs. The GPCs then fuse with the plasma membrane at sites where its membrane protrusions form a structure termed a "fibripositor", which extrudes a single long collagen fibril into the ECM. The alternative model proposed by Birk 38 is similar in many respects. In this model, GPCs fuse with invaginations of the cell membrane, termed "fibril forming channels". Birk proposes that procollagen processing into tropocollagen occurs extracellularly, in the fibril forming channels. There appears to be evidence supporting both models and it seems possible that both mechanisms could occur simultaneously and/or that the mechanisms of collagen fibrillogenesis may be different in embryonic development compared to postnatally 39, 40 . Once the initial fibril is formed, collagen molecules can attach to the fibril ends or associate laterally to increase fibril length and width.
The above models were developed from detailed TEM observations in tendons with highly ordered collagen fibrils arranged in a single direction. While it is quite possible that similar assembly mechanisms exist in other collagen-producing cell types, it is also possible that mechanisms may vary depending on the requirements for collagen organization in each tissue. In the context of the Kadler and Birk models, our co-culture data with cells expressing GFPtpz and mCherry-collagen are interesting because they allowed us to examine experimentally whether cells cooperate in the assembly of collagen fibers or if individual cells assemble their own fibers. Various co-culture formats, including 1:1 mixtures of MLO-colGFP and MLO-colCherry cells, interface cultures of the two cell lines or "parachuting" MLO-colCherry cells at low densities onto a layer of MLO-colGFP cells, all suggested cooperation of multiple cells in collagen assembly, since the collagen formed in all three models contained red and green collagen in the same fibers. Double immunogold labeling in MLO-colCherry/MLO-colGFP co-cultures further showed that mCherry and GFPtpz-collagen were localized in the same fibril, suggesting that more than one cell provides contributions to an individual fibril. If the Kadler and/or Birk models are correct, our observation of mCherry and GFPtpz-collagen in the same fibril likely represents lateral association of collagen from one cell onto the initial fibrils formed by another cell. The "parachute" and "interface" experiments are also interesting as they suggest that secreted collagen does not diffuse significant distances away from the producer cell to be incorporated into the ECM at distant sites. This supports a mechanism in which cells actively place collagen into the ECM and is compatible with the Kadler and Birk models of collagen placement by "fibripositor" or "fibril forming channel" structures.
From our collagen live imaging studies, a number of key novel concepts have emerged. Firstly, assembly of collagen fibril networks is highly dynamic, with the osteoblasts constantly moving during the assembly process. This cell motion exerts forces on the forming fibrils, resulting in repeated stretching and contraction and subjecting them to mechanical strain. To our knowledge, these are the first long term timelapse studies that have allowed dynamic visualization of the assembly of complex extracellular collagen networks. Previous timelapse studies of elastin 11, 41 and fibronectin 15 have shown the assembly of these two ECM proteins to be highly dynamic. One possibility is that mechanical stretching of collagen fibrils could facilitate the assembly process by unmasking binding sites on collagen molecules to make them available for protein-protein interactions. This type of mechanism was proposed for fibronectin, whereby it is thought that mechanical stretching of fibronectin molecules via binding to cell surface integrins that translocate along the actin cytoskeleton opens up the globular fibronectin molecules to reveal cryptic fibronectin selfbinding sites [42] [43] [44] . Mechanical stretching of collagen fibrils in bone ECM by cell motions during assembly could facilitate fibril expansion by similar mechanisms and future work is needed to investigate this. The repeated stretching and relaxing of fibronectin fibrils due to cell motion may also expose collagen binding sites on fibronectin molecules that may in turn facilitate collagen assembly.
Our live imaging studies showed that without ascorbate the mCherry or GFPtpz-collagen showed an intracellular, perinuclear ER-like distribution. Upon ascorbate addition, the collagen migrated into vesicle-like structures. These moved actively within the cell and appeared to be involved in collagen deposition, raising the possibility that they are a secretory vesicle, such as a GPC or the large diameter transport carriers containing processed collagen described in tendon fibroblasts 39 . Another possibility is that these are the osteoblasts' equivalent to the "fibripositor" or "fibril forming channels" described in the Kadler and Birk Models of collagen fibrillogenesis. Similar structures were seen in time lapse imaging of elastin assembly 11 and although not mentioned in the paper by Ohashi et al 45 , are apparent in their images of cells expressing YFP-fibronectin, suggesting this might be a common feature in assembly of ECM proteins.
A particularly interesting new observation from our timelapse movies was that osteoblasts could physically reshape the collagen matrix by pushing collagen outwards to form holes in the fibril network. To our knowledge, this ability of cells to reshape collagen has not previously been reported, although we have shown that osteoblasts can physically reshape fibronectin and LTBP1 in the ECM by shunting fibrils from one location to another and exchanging fibrillar material between fibrils 15 . Rongish and colleagues have used live imaging to analyze fibronectin and fibrillin dynamics in early avian embryos 10, 12, 41 . They identified two types of motion of ECM filaments, one in which filaments are moved by large-scale tissue motions during morphogenesis and another in which motion of individual filaments is driven by motility/protrusive activity of nearby cells. Breaking and recoil of fibronectin fibrils by cell-mediated forces has also been reported using live cell imaging 45, 46 . Our studies now suggest that osteoblasts can physically reshape collagen after it has been deposited and we are currently investigating whether this reshaping to form holes may provide a potential mechanism for formation of a nascent osteocyte lacuna.
Our live imaging in FN-null-MEFs, confirms an important role for fibronectin in collagen assembly, as has been shown in static experiments [32] [33] [34] , and expands on prior work by allowing us to simultaneously visualize the kinetics of their deposition and determine how their assembly is dynamically integrated. Without fibronectin, few collagen fibrils were assembled but with exogenous fibronectin, collagen deposition was dramatically enhanced. Two color live imaging in FNKO-colGFP cells supplemented with fibronectin showed that GFPtpz-collagen co-assembled with fibronectin, with fibronectin deposition preceding collagen, suggesting that fibronectin forms a template for the initial deposition of collagen and that their assembly is dynamically integrated. Fibronectin is also required for assembly of other ECM proteins, such as latent transforming growth factor beta binding protein-1 47 and fibrillin-1 48 and thus may be a central nucleator for ECM deposition. Our current data suggest that in longer term culture up to 6 days, there may be later remodeling events in which collagen and fibronectin are reorganized into separate fibrils, likely through fibronectin turnover, suggesting that fibronectin may provide a temporary scaffold for collagen deposition. Future studies are needed to further investigate this using longer term live imaging. Turnover of fibronectin has been reported in vitro in the absence of continual fibronectin polymerization 32, 49 and this fibronectin degradation is thought to be via caveolin-1 dependent endocytosis followed by lysosomal degradation 49 , however, it remains to be determined whether this also occurs in vivo.
One limitation of the current study is that the experiments were performed in immortalized osteoblast-like cell lines, which continue to divide. This may not accurately model lamellar bone formation in vivo, where collagen is deposited in a more highly organized manner by osteoblasts aligned on a mineralization front and the fibers are predominantly oriented longitudinally. It is likely that the collagen deposition we have visualized using our in vitro cell models is more relevant to woven and/or intramembranous bone formation, where collagen is rapidly deposited and is more disorganized. Future studies using these GFP-and mCherry-tagged collagen constructs in transgenic animal models will shed light on whether similar mechanisms occur in vivo in developmental and postnatal bone formation as well as in fracture healing.
In summary, we have developed and validated GFPtpz and mCherry-collagen fusion constructs and employed them for the first time in long-term time lapse imaging studies to reveal the dynamics of extracellular collagen deposition. Live imaging in osteoblasts stably expressing these constructs has shown that the ECM assembly of collagen is more dynamic than previously known and is integrated with motile cell function. It has also revealed that cell-generated forces constantly stretch and contract the forming fibrils and that multiple cells contribute to the formation of collagen fibrils. Using these constructs in a fibronectin null cell model has confirmed the dependence of collagen assembly on fibronectin deposition and has shown that the assembly of these ECM proteins is dynamically integrated. The continued study of ECM assembly kinetics using live imaging approaches will provide important insights into the cellular mechanisms by which the ECM is assembled and reorganized. These novel tools for collagen imaging can also be used for examining kinetically the influence of other molecules in bone, such as decorin and biglycan, which regulate collagen fibril assembly 50 , as well as growth factors such as TGFβ and Wnts that promote collagen assembly. Furthermore, these collagen imaging probes can have wide applications in understanding skeletal biology and in studies of wound healing, tissue regeneration, and diseases such as fibrosis, cancer metastasis, and inherited connective tissue disorders. showing MLO-colGFP cells imaged without ascorbate. A cell, X, starts dividing at 3h and shares its GFPtpz-collagen content equally between daughter cells, X 1 and X 2 . D) Enlarged view of still frames from movie 2 showing MLO-colGFP cells imaged with ascorbate. A cell, Z, starts dividing after 19h and shares its collagen content equally between daughter cells, Z 1 and Z 2 . A second cell, Y divides by 20h and also shares its collagen content equally
